Etomethazene (5-methyldesnitroetonitazene, 5-methyl etodesnitazene, Eto) is a benzimidazole derivative with opioid effects which has been sold as a designer drug over the internet since 2022, first being definitively identified in Sweden in January 2023. It is an analogue of etonitazene where the nitro (NO2) group has been replaced by a methyl (CH3) group. It is less potent than etonitazene itself but still has around twice the potency of fentanyl. Etomethazene has a relatively short duration of action of about 120 min.
See also Etoacetazene Etocyanazene Etodesnitazene Etonitazepyne Isotonitazene Metonitazene List of benzimidazole opioids
References